Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 9, 2010, Pages 4009-4011

  Biedenbach, Douglas J ^a   Castanheira, Mariana ^a   Jones, Ronald N ^a,b  

^a JMI LABORATORIES   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFTRIAXONE; CEM 101; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MINOCYCLINE; PENICILLIC ACID; RIFAMPICIN; TELITHROMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DRUG DETERMINATION; MENINGOCOCCOSIS; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CEFTRIAXONE; CIPROFLOXACIN; HUMANS; KETOLIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; NEISSERIA MENINGITIDIS; PENICILLINS; RIFAMPIN; SULFAMETHOXAZOLE; TRIAZOLES; TRIMETHOPRIM;

EID: 77956102065     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01812-09     Document Type: Article

References (22)

1. Alcala, B., C. Salcedo, L. de la Fuente, L. Arreaza, M. J. Uria, R. Abad, R. Enriquez, J. A. Vazquez, M. Motge, and J. de Batlle. 2004. Neisseria meningitidis showing decreased susceptibility to ciprofloxacin: first report in Spain. J. Antimicrob. Chemother. 53:409.
2. Antignac, A., M. Ducos-Galand, A. Guiyoule, R. Pires, J. M. Alonso, and M. K. Taha. 2003. Neisseria meningitidis strains isolated from invasive infections in France (1999-2002): phenotypes and antibiotic susceptibility patterns. Clin. Infect. Dis. 37:912-920.
3. Artenstein, M. S. 1975. Prophylaxis for meningococcal disease. JAMA 231:1035-1037.
4. Centers for Disease Control and Prevention. 2008. Emergence of fluoroquinolone-resistant Neisseria meningitidis - Minnesota and North Dakota, 2007-2008. MMWR Morb. Mortal. Wkly. Rep. 57:173-175.
5. Chu, Y. W., T. K. Cheung, V. Tung, F. Tiu, J. Lo, R. Lam, R. Lai, and K. K. Wong. 2007. A blood isolate of Neisseria meningitidis showing reduced susceptibility to quinolones in Hong Kong. Int. J. Antimicrob. Agents 30:94-95.
6. Clinical and Laboratory Standards Institute. 2009. M07-A8. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - eighth edition. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Clinical and Laboratory Standards Institute. 2009. M100-S19. Performance standards for antimicrobial susceptibility testing. 19th informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Corso, A., D. Faccone, M. Miranda, M. Rodriguez, M. Regueira, C. Carranza, C. Vencina, J. A. Vazquez, and M. Galas. 2005. Emergence of Neisseria meningitidis with decreased susceptibility to ciprofloxacin in Argentina. J. Antimicrob. Chemother. 55:596-597.
9. Cousin, S., Jr., W. L. Whittington, and M. C. Roberts. 2003. Acquired macrolide resistance genes in pathogenic Neisseria spp. isolated between 1940 and 1987. Antimicrob. Agents Chemother. 47:3877-3880.
10. Enriquez, R., R. Abad, C. Salcedo, S. Perez, and J. A. Vazquez. 2008. Fluoroquinolone resistance in Neisseria meningitidis in Spain. J. Antimicrob. Chemother. 61:286-290.
11. Florez, C., J. L. Garcia-Lopez, and E. Martin-Mazuelos. 1997. Susceptibilities of 55 strains of Neisseria meningitidis isolated in Spain in 1993 and 1994. Chemotherapy 43:168-170.
12. Girgis, N., Y. Sultan, R. W. Frenck, Jr., A. El-Gendy, Z. Farid, and A. Mateczun. 1998. Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis. Pediatr. Infect. Dis. J. 17:816-819.
13. Lapadula, G., F. Vigano, P. Fortuna, A. Dolara, S. Bramati, A. Soria, S. Foresti, and A. Gori. 2009. Imported ciprofloxacin-resistant Neisseria meningitidis. Emerg. Infect. Dis. 15:1852-1854.
14. Llano-Sotelo, B., D. Klepacki, and A. S. Mankin. 2008. Binding and action of CEM-101, a new macrolide/ketolide in development for treating infections with macrolide-resistant and macrolide-susceptible bacteria, abstr. F1-3983. Abstr. 48th Annu. Intersci. Conf. Antimicrob. Agents Chemother. (ICAAC)- Infect. Dis. Soc. Am. (IDSA) 46th Annu. Meet. American Society for Microbiology and Infectious Diseases Society of America, Washington, DC.
15. Manchanda, V., and P. Bhalla. 2006. Emergence of non-ceftriaxone- susceptible Neisseria meningitidis in India. J. Clin. Microbiol. 44:4290-4291.
16. Oppenheim, B. A. 1997. Antibiotic resistance in Neisseria meningitidis. Clin. Infect. Dis. 24(Suppl. 1):S98-S101.
17. Richter, S. S., K. A. Gordon, P. R. Rhomberg, M. A. Pfaller, and R. N. Jones. 2001. Neisseria meningitidis with decreased susceptibility to penicillin: report from the SENTRY antimicrobial surveillance program, North America, 1998-99. Diagn. Microbiol. Infect. Dis. 41:83-88.
18. Shultz, T. R., P. A. White, and J. W. Tapsall. 2005. In vitro assessment of the further potential for development of fluoroquinolone resistance in Neisseria meningitidis. Antimicrob. Agents Chemother. 49:1753-1760.
19. Skoczynska, A., J. M. Alonso, and M. K. Taha. 2008. Ciprofloxacin resistance in Neisseria meningitidis, France. Emerg. Infect. Dis. 14:1322-1323.
20. Stefanelli, P., A. Neri, A. Carattoli, and P. Mastrantonio. 2007. Detection of resistance to rifampicin and decreased susceptibility to penicillin in Neisseria meningitidis by real-time multiplex polymerase chain reaction assay. Diagn. Microbiol. Infect. Dis. 58:241-244.
21. Weiss, D., E. J. Stern, C. Zimmerman, B. Bregman, A. Yeung, D. Das, C. M. Dentinger, M. A. Marx, J. Kornblum, L. Lee, T. A. Halse, L. W. Mayer, C. P. Hatcher, M. J. Theodore, S. Schmink, B. H. Harcourt, J. R. Zucker, M. Layton, and T. A. Clark. 2009. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York. Clin. Infect. Dis. 48:894-901.
22. Wu, H. M., B. H. Harcourt, C. P. Hatcher, S. C. Wei, R. T. Novak, X. Wang, B. A. Juni, A. Glennen, D. J. Boxrud, J. Rainbow, S. Schmink, R. D. Mair, M. J. Theodore, M. A. Sander, T. K. Miller, K. Kruger, A. C. Cohn, T. A. Clark, N. E. Messonnier, L. W. Mayer, and R. Lynfield. 2009. Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America. N. Engl. J. Med. 360:886-892.